MXPA03005343A - Composiciones antiacidas liquidas. - Google Patents

Composiciones antiacidas liquidas.

Info

Publication number
MXPA03005343A
MXPA03005343A MXPA03005343A MXPA03005343A MXPA03005343A MX PA03005343 A MXPA03005343 A MX PA03005343A MX PA03005343 A MXPA03005343 A MX PA03005343A MX PA03005343 A MXPA03005343 A MX PA03005343A MX PA03005343 A MXPA03005343 A MX PA03005343A
Authority
MX
Mexico
Prior art keywords
weight percent
amount
containing compounds
liquid antacid
glycerin
Prior art date
Application number
MXPA03005343A
Other languages
English (en)
Inventor
L Hansenmayer Donald
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA03005343A publication Critical patent/MXPA03005343A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proveen preparaciones antiacidas liquidas que comprenden: a) un compuesto activo neutralizante de acido seleccionado del grupo que consiste de compuestos que contienen calcio, compuestos que contienen aluminio, compuestos que contienen magnesio, y mezclas de los mismos; y b) un adyuvante antimicrobiano seleccionado del grupo que consiste de propilenglicol en una cantidad mayor de 2% en peso y menor de 15% en peso, glicerina en una cantidad de alrededor de 15 a aproximadamente 20% en peso, y combinaciones de propilenglicol en una cantidad de alrededor de 3 a aproximadamente 10% en peso con glicerina, en una cantidad de alrededor de 3 a aproximadamente 10% en peso con base en el peso total de la preparacion.
MXPA03005343A 2002-06-14 2003-06-13 Composiciones antiacidas liquidas. MXPA03005343A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/171,707 US20030232092A1 (en) 2002-06-14 2002-06-14 Liquid antacid compositions

Publications (1)

Publication Number Publication Date
MXPA03005343A true MXPA03005343A (es) 2004-10-29

Family

ID=29717770

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005343A MXPA03005343A (es) 2002-06-14 2003-06-13 Composiciones antiacidas liquidas.

Country Status (20)

Country Link
US (1) US20030232092A1 (es)
EP (1) EP1374874B1 (es)
JP (1) JP2004035551A (es)
KR (1) KR20030096085A (es)
CN (1) CN1470246A (es)
AR (1) AR039693A1 (es)
AT (1) ATE340582T1 (es)
AU (1) AU2003204688B2 (es)
BR (1) BR0302470A (es)
CA (1) CA2432231A1 (es)
DE (1) DE60308595T2 (es)
ES (1) ES2271483T3 (es)
HU (1) HUP0301715A2 (es)
MX (1) MXPA03005343A (es)
NZ (1) NZ526459A (es)
PL (1) PL360680A1 (es)
PT (1) PT1374874E (es)
RU (1) RU2322246C2 (es)
SA (1) SA03240232B1 (es)
ZA (1) ZA200304650B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080260823A1 (en) * 2007-04-20 2008-10-23 Sciele Pharma, Inc. Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
RU2635276C1 (ru) 2016-06-24 2017-11-09 Акционерное общество "Лаборатория Касперского" Безопасная аутентификация по логину и паролю в сети Интернет с использованием дополнительной двухфакторной аутентификации
CN108721213A (zh) * 2017-04-13 2018-11-02 辽宁大熊制药有限公司 铝镁混悬液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL32020A (en) * 1968-04-18 1972-11-28 Brown G Antacid compositions
JPH0692309B2 (ja) * 1986-11-22 1994-11-16 富士化学工業株式会社 懸濁制酸剤
AU3328193A (en) * 1991-12-17 1993-07-19 Fuisz Technologies Ltd. Ulcer prevention and treatment composition and method
EP0700283B1 (en) * 1993-05-26 1998-11-25 The Procter & Gamble Company Liquid antacid compositions
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
JP3615894B2 (ja) * 1997-01-20 2005-02-02 株式会社ノエビア 抗菌性低刺激化粧料

Also Published As

Publication number Publication date
AR039693A1 (es) 2005-03-09
RU2322246C2 (ru) 2008-04-20
ATE340582T1 (de) 2006-10-15
EP1374874A2 (en) 2004-01-02
DE60308595T2 (de) 2007-08-09
HU0301715D0 (en) 2003-08-28
US20030232092A1 (en) 2003-12-18
BR0302470A (pt) 2004-08-24
EP1374874B1 (en) 2006-09-27
ZA200304650B (en) 2005-01-24
SA03240232B1 (ar) 2007-07-31
KR20030096085A (ko) 2003-12-24
NZ526459A (en) 2004-11-26
AU2003204688A1 (en) 2004-01-15
EP1374874A3 (en) 2004-01-07
DE60308595D1 (de) 2006-11-09
HUP0301715A2 (hu) 2005-07-28
PT1374874E (pt) 2006-12-29
CN1470246A (zh) 2004-01-28
ES2271483T3 (es) 2007-04-16
PL360680A1 (en) 2003-12-15
CA2432231A1 (en) 2003-12-14
AU2003204688B2 (en) 2008-04-10
JP2004035551A (ja) 2004-02-05

Similar Documents

Publication Publication Date Title
EP1100522A4 (en) ADMINISTRATION OF ACTIVE SUBSTANCES BY PULMONARY TRACT
AR046933A1 (es) Eficacia de humectacion mejorada mediante el uso de hidroxialquilurea
CA2411754A1 (en) 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
BR0109251A (pt) Formulação agrotécnica, e, uso de um ciclo-hexanopolicarboxato de di(isononila)
CA2172493A1 (en) Use of angiotensin iii and analogs thereof in tissue repair
NO20013700D0 (no) GCSF-konjugater
WO2006060515A3 (en) System for improved percutaneous absorption of skin benefiting agents
WO2005000241A3 (en) Compositons and methods for topical administration
AU3956599A (en) Surfactant for use in external preparations for skin and external preparation for skin containing the same
CA2504797A1 (en) Base for oral composition and the oral composition
WO2005000248A3 (en) Compositions and methods for skin conditioning
EP2404501A3 (en) Package preservation for cosmetic formulations
NZ506678A (en) Inorganic nitrite and organic acid in combination as topical antiviral composition
WO2002015959A3 (en) Compounds and compositions for delivering active agents
BR9714839A (pt) Composições antitranspirantes em bastão de gel sólido
CA2359491A1 (en) Mixture of plant treatment compositions with waxes, their preparation, and their use
WO2002024665A8 (en) Arylalkane-sulfonamides having endothelin-antagonist activity
MXPA03005343A (es) Composiciones antiacidas liquidas.
RS20060154A (en) Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents
GB2362103B (en) Pharmaceutical compositions including alginates
IL152328A (en) Preparations containing a combination of defibrotide and one or more hematopoietic factors and their use
WO2002005759A8 (de) Dekorative kosmetische zubereitungen dialkylcarbonate und metalloxide enthaltend
NZ528544A (en) Formulations comprising entrapped active ingredients and uses thereof
BRPI0412453A (pt) uso do ácido ascórbico ou um sal fisiologicamente aceitável do mesmo
ES2152666T3 (es) Compuesto para rehidratacion oral comprendiendo glutamina.

Legal Events

Date Code Title Description
FG Grant or registration